> if one pharma had a cure, it would put the others out of business It wouldn't though, because most pharma companies are diversified somewhat. However, if you

> if one pharma had a cure, it would put the others out of business It wouldn't though, because most pharma companies are diversified somewhat. However, if your company has little in the pipeline except a cure where your competitors are more diversified, you have strong incentives to sit on a cure for a bit.